UCSF Receives 10 NIH Grants to Study Pain and Opioid Addiction The National Institutes of Health (NIH) recently awarded 10 grants to UC San Francisco researchers as part of the NIH Helping to End Addiction Long-term (HEAL) Initiative. These awards have totaled more than $40 million, with the purpose of funding projects such as:
Improved technologies for MRI imaging of back pain Utilization of deep-brain stimulation for treating chronic pain New interdisciplinary research center for low back pain
Dr. Faustino Bernadett has long been involved with UCSF, so this news hits home for him. Not only is he a proud alumnus of University of California, San Francisco (UCSF) School of Medicine, Dr. Faustino was the UC San Francisco Board Overseer, UCSF Campaign Donation Supporter and created a UCSF scholarship in honor of his father, Faustino Bernadett, Sr. Faustino Bernadett, along with his wife, also established the Faustino and Martha Molina Bernadett Presidential Chair for Education in the UCSF School of Medicine. It stands as no surprise, then that he views the NIH grants as a source of pride for his alma mater. After all, he has dedicated his life as a doctor of pain management.
Pain Management and Opioid Addiction According to the CDC, 50 million U.S. adults suffer from chronic pain, one of the most common reasons they seek medical care. But chronic pain has been linked to restrictions in mobility and daily activities, dependence on opioids, anxiety, depression, and reduced quality of life. Chronic pain is defined as pain that lasts longer than three consecutive months. Low back pain, headaches, arthritis, and neuropathy top the list of causes, costing the country $635 billion annually. In 2018 alone, more than a million Americans age 12 and older misused opioids, including heroin. Opioid addiction is a long-lasting disease that can lead to major health, social, and economic problems. This class of drugs affects the nervous system to produce feelings of pleasure and pain relief. Some opioids are legally prescribed by healthcare providers, and those include oxycodone, fentanyl,